featured news

False Perceptions About The False Claims Act

The federal False Claims Act (“FCA”) is widely-touted as one of the most successful pieces of legislation in American history. Its success is rooted in the incentivization of integrity which, right or wrong, seems to work. To date, the FCA has been pivotal in the U.S. government recouping billions of […]

Department of Justice Announces Severe Penalties Against Lymphedema & Wound Care Institute

Federal law prohibits private companies from engaging in fraudulent misconduct and misspending of federal funds. This includes all contractors doing business with the federal government or any entity receiving federal funds through a reimbursement program. One of the top sources of federal fraud arises in the healthcare industry and is […]

Review of OIG’s Strategic Five-Year Plan Spotlights Need for False Claims Act Attorneys

The Department of Health and Human Services has been under close scrutinization since the implementation of the Affordable Care Act and its accompanying internet portal healthcare.gov. Notwithstanding this unprecedented, unexpected public scrutiny, the HHS has published for public review a report of its goals and aspirations through 2018, which include […]

Review of SEC’s Report to Congress on the Impact of Dodd-Frank’s Whistleblower Reform, Pt 4

All this week, we have been focusing on whistleblower protections as they pertain to the securities market. Whistleblowers with original information of trading, disclosure or other types of fraud are now able to make reports of misconduct under the new qui tam provisions of the Dodd-Frank Act, which was enacted […]

Review of SEC’s Report to Congress on the Impact of Dodd-Frank’s Whistleblower Reform, Pt 3

Over the past several days, we have reviewed a recent report submitted to Congress by the Securities and Exchange Commission detailing its unveiling of the Office of Whistleblower Protection (OWB). The OWB was set up in response to the 2010 Dodd-Frank Act, which effectuated Wall Street reform and is designed […]

Review of SEC’s Report to Congress on the Impact of Dodd Frank’s Whistleblower Reform, Pt 2

In yesterday’s post, we introduced and began reviewing the recent report submitted to Congress by the SEC. It provides helpful details and insight into the whistleblower program advanced by the Dodd Frank Act as well as an analysis of fiscal year 2013 and the highlights therein, including a record-breaking $14 […]

Review of SEC Report to Congress on the Impact of Dodd Frank’s Whistleblower Reform, Pt 1

As we reported last week, the Dodd-Frank Wall Street Reform and Consumer Protection Act has been highly integral in protecting investors and taxpayers as well as holding fraudulent investors and corporate managers responsible for their misdeeds. Earlier this month, the Securities Exchange Commission, an entity responsible for overseeing the securities […]

Understanding the Four Key Whistleblower Statutes Under Federal Law

Our blog often discusses litigation surrounding the False Claims Act, which is the hallmark whistleblower statute in the United States. Enacted during the Civil War, the FCA and its incentivizing qui tam provisions paved the way for other government entities to advocate for Congress to enact similar provisions in their […]

The Effect of the Affordable Care Act Upon the Federal Anti-Kickback Statute

According to the Department of Health and Human Services, the federal anti-kickback statute serves one purpose: to protect patients and the federal health care programs from fraud and abuse by curtailing the corrupting influence of money on health care decisions. As we have reported in the past, this law has proven […]

Vantage Oncology Center to Pay $2 Million to Settle False Claims Act Allegations

In yet another case of unlawful Medicare billing, Vantage Oncology Center has agreed to pay $2 million to settle allegations it defrauded federal healthcare entities including Medicare and Medicaid. This case comes on the heels of a recent mega-settlement by neighbor Omnicare, Inc., a pharmacy services company alleged to have […]

JM Eagle Prepared to Immediately Appeal False Claims Act Verdict

The False Claims Act is a piece of federal legislation, created by Congress in the mid-1800’s, that permits private individuals to file a cause of action on behalf of the U.S. government based on allegations of fraud or misspending of federal tax dollars. As we have reported in the past, […]

LG Chem Agrees to $1.2 Million False Claims Act Settlement

Technology giant LG Chem announced earlier this month that it will pay $1.2 million to settlement claims under the False Claims Act. The settlement, which does not admit wrongdoing or liability, comes as a result of the government’s accusations that the company mismanaged federal funds and provided employees unnecessary benefits […]